protease cleavage sites targeting vaccine (University of Manitoba/University of Nairobi/University of Santiago de Compostela)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameprotease cleavage sites targeting vaccine (University of Manitoba/University of Nairobi/University of Santiago de Compostela)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaSpainKenya

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Manitoba

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Manitoba University Of Santiago De Compostela University Of Nairobi

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A